Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
The reason I expect a higher price comes from experience going into p3 results with multiple other non-revenue/micro biotechs over the last couple decades. A run-up prior to results is almost the "norm". It has happened even when failure was the majority expectation. It is happening this year with several other small biotechs.
One could argue, I guess, that it has already happened here, but I think there is more to come.
